Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.

Li, An-Rong; Johnson, Michael G; Liu, Jiwen; Chen, Xiaoqi; Du, Xiaohui; Mihalic, Jeffrey T; Deignan, Jeffrey; Gustin, Darin J; Duquette, Jason; Fu, Zice; Zhu, Liusheng; Marcus, Andrew P; Bergeron, Phillipe; McGee, Lawrence R; Danao, Jay; Lemon, Bryan; Carabeo, Teresa; Sullivan, Timothy; Ma, Ji; Tang, Liang; Tonn, George; Collins, Tassie L; Medina, Julio C

Li, An-Rong; Johnson, Michael G; Liu, Jiwen; Chen, Xiaoqi; Du, Xiaohui; Mihalic, Jeffrey T; Deignan, Jeffrey; Gustin, Darin J; Duquette, Jason; Fu, Zice; Zhu, Liusheng; Marcus, Andrew P; Bergeron, Phillipe; McGee, Lawrence R; Danao, Jay; Lemon, Bryan; Carabeo, Teresa; Sullivan, Timothy; Ma, Ji; Tang, Liang; Tonn, George; Collins, Tassie L; Medina, Julio C.

Affiliation

Li AR; Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA.

Bioorg Med Chem Lett ; 18(2): 688-93, 2008 Jan 15.

Article in En | MEDLINE | ID: mdl-18061451

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinazolinones / Receptors, CXCR3 / Heterocyclic Compounds Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links